Is it COVID-19? The value of medicolegal autopsies during the first year of the COVID-19 pandemic
Copyright © 2021 Elsevier B.V. All rights reserved..
OBJECTIVES: We describe the experience of a busy metropolitan medical examiner's office in the United States and share our navigation of the COVID-19 autopsy decision-making process. We describe key gross and microscopic findings that, with appropriate laboratory testing, should direct a pathologist towards a COVID-19-related cause of death.
MATERIAL AND METHODS: We performed a retrospective review of 258 suspected and/or confirmed COVID-19 associated deaths that occurred between March 5, 2020, and March 4, 2021.
RESULTS: A total of 62 cases due to fatal COVID-19 were identified; autopsy findings included diffuse alveolar damage, acute bronchopneumonia and lobar pneumonia, and pulmonary thromboemboli. Nine additional decedents had a nasopharyngeal swab positive for SARS-CoV-2 and a cause of death unrelated to COVID-19. Forty-seven cases with COVID-19-like symptoms showed no laboratory or histopathologic evidence of SARS-CoV-2 infection; the most common causes of death in this group were hypertensive or atherosclerotic cardiovascular disease, complications of chronic alcoholism, and pulmonary thromboemboli unrelated to infection.
CONCLUSIONS: The clinical findings associated with COVID-19 are not specific; a broad differential diagnosis should be embraced when decedents present with cough or shortness of breath. An autopsy may be indicated to identify a cause of death unrelated to COVID-19.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:330 |
---|---|
Enthalten in: |
Forensic science international - 330(2022) vom: 18. Jan., Seite 111106 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Geller, Rachel L [VerfasserIn] |
---|
Links: |
---|
Themen: |
Autopsy |
---|
Anmerkungen: |
Date Completed 11.01.2022 Date Revised 21.12.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.forsciint.2021.111106 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM333638859 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM333638859 | ||
003 | DE-627 | ||
005 | 20231225222048.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.forsciint.2021.111106 |2 doi | |
028 | 5 | 2 | |a pubmed24n1112.xml |
035 | |a (DE-627)NLM333638859 | ||
035 | |a (NLM)34826762 | ||
035 | |a (PII)S0379-0738(21)00426-6 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Geller, Rachel L |e verfasserin |4 aut | |
245 | 1 | 0 | |a Is it COVID-19? The value of medicolegal autopsies during the first year of the COVID-19 pandemic |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.01.2022 | ||
500 | |a Date Revised 21.12.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2021 Elsevier B.V. All rights reserved. | ||
520 | |a OBJECTIVES: We describe the experience of a busy metropolitan medical examiner's office in the United States and share our navigation of the COVID-19 autopsy decision-making process. We describe key gross and microscopic findings that, with appropriate laboratory testing, should direct a pathologist towards a COVID-19-related cause of death | ||
520 | |a MATERIAL AND METHODS: We performed a retrospective review of 258 suspected and/or confirmed COVID-19 associated deaths that occurred between March 5, 2020, and March 4, 2021 | ||
520 | |a RESULTS: A total of 62 cases due to fatal COVID-19 were identified; autopsy findings included diffuse alveolar damage, acute bronchopneumonia and lobar pneumonia, and pulmonary thromboemboli. Nine additional decedents had a nasopharyngeal swab positive for SARS-CoV-2 and a cause of death unrelated to COVID-19. Forty-seven cases with COVID-19-like symptoms showed no laboratory or histopathologic evidence of SARS-CoV-2 infection; the most common causes of death in this group were hypertensive or atherosclerotic cardiovascular disease, complications of chronic alcoholism, and pulmonary thromboemboli unrelated to infection | ||
520 | |a CONCLUSIONS: The clinical findings associated with COVID-19 are not specific; a broad differential diagnosis should be embraced when decedents present with cough or shortness of breath. An autopsy may be indicated to identify a cause of death unrelated to COVID-19 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Autopsy | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Mortality | |
650 | 4 | |a Retrospective | |
650 | 4 | |a SARS-CoV-2 | |
700 | 1 | |a Aungst, Jenna L |e verfasserin |4 aut | |
700 | 1 | |a Newton-Levinson, Anna |e verfasserin |4 aut | |
700 | 1 | |a Smith, Geoffrey P |e verfasserin |4 aut | |
700 | 1 | |a Mosunjac, Marina B |e verfasserin |4 aut | |
700 | 1 | |a Mosunjac, Mario I |e verfasserin |4 aut | |
700 | 1 | |a Cunningham, Christy S |e verfasserin |4 aut | |
700 | 1 | |a Gowitt, Gerald T |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Forensic science international |d 1983 |g 330(2022) vom: 18. Jan., Seite 111106 |w (DE-627)NLM000402508 |x 1872-6283 |7 nnns |
773 | 1 | 8 | |g volume:330 |g year:2022 |g day:18 |g month:01 |g pages:111106 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.forsciint.2021.111106 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 330 |j 2022 |b 18 |c 01 |h 111106 |